STOCK TITAN

Science Magazine Recognizes Incyte as #2 “Top Employer” of 2023

Rhea-AI Impact
(No impact)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary
Incyte recognized as a top employer for the sixth consecutive year by Science magazine, ranking second on the list and praised for loyal employees and social responsibility.
Positive
  • Incyte ranked second on the list of top employers by Science magazine for the sixth consecutive year, two spots higher than last year's ranking.
  • Incyte was specifically recognized for its loyal employees and commitment to social responsibility.
  • Being named a top employer by Science magazine helps maintain the energy and excitement of the company.
Negative
  • None.

WILMINGTON, Del.--(BUSINESS WIRE)-- Science magazine announced today that for the sixth consecutive year, Incyte has been named a top five employer based on its annual survey of approximately 6,800 individuals. Incyte ranked second on this year’s list, two spots higher than its 2022 ranking, and was specifically recognized for its loyal employees, social responsibility and treating employees with respect.

Incyte is proud to be recognized as a top employer by Science and seeks to create an environment where innovation, collaboration and respect for each other are prioritized. Incyte is guided by its mission to Solve On. for patients around the world – it is a workplace where problems get solved and lives are transformed. Every Incyte employee plays a role in achieving this goal, and the Company is dedicated to creating an atmosphere where employees can grow and thrive to their full potential.

“For more than 20 years, we have focused on creating a culture that fosters innovation, fuels our mission to Solve On. and inspires and energizes our employees as they pursue advances for patients in need. Recognitions like this one from Science magazine, as well as being named one of America’s 100 Most Loved Workplaces and one of the Most Loved Global Workplaces by Newsweek, mean so much and help us maintain the energy and excitement that motivate us as individuals, and as a company, every day,” said Paula Swain, Executive Vice President, Human Resources, Incyte.

The complete Science magazine Top Employers survey feature, along with individual company rankings, is available in the October 27, 2023 print issue of Science and online: https://www.science.org/content/article/making-happy-workplace-employees.

About Incyte

Incyte is a Wilmington, Delaware-based, global biopharmaceutical company focused on finding solutions for serious unmet medical needs through the discovery, development and commercialization of proprietary therapeutics. For additional information on Incyte, please visit Incyte.com and follow @Incyte.

Media

media@incyte.com

Source: Incyte

FAQ

What is Incyte recognized for?

Incyte is recognized as a top employer by Science magazine for its loyal employees and social responsibility.

How does Incyte rank on the list of top employers?

Incyte ranked second on the list of top employers by Science magazine, two spots higher than last year's ranking.

What impact does being named a top employer have on Incyte?

Being named a top employer by Science magazine helps maintain the energy and excitement of the company.

Incyte Genomics Inc

NASDAQ:INCY

INCY Rankings

INCY Latest News

INCY Stock Data

12.07B
186.98M
1.58%
100.2%
3.59%
Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
Professional, Scientific, and Technical Services
Link
United States of America
WILMINGTON

About INCY

incyte is a biopharmaceutical company focused on the discovery, development and commercialization of proprietary therapeutics, primarily for oncology. our vision is to become a leader in the development and delivery of novel drugs for serious unmet medical needs. we have established multiple collaborations with major pharmaceutical companies to support the clinical development and global commercialization of several of our compounds. the incyte corporate headquarters is located in wilmington, delaware, and more than 625 employees comprise our experienced management, discovery, clinical development and commercial teams. our assets, experience and prior success in bringing important new drugs to market put us in a strong position to make a difference by improving the lives of patients and building sustainable value for our shareholders. for more information about incyte, please visit our corporate website at www.incyte.com.